BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18692266)

  • 1. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC.
    Cattaneo GM; Dell'oca I; Broggi S; Fiorino C; Perna L; Pasetti M; Sangalli G; di Muzio N; Fazio F; Calandrino R
    Radiother Oncol; 2008 Sep; 88(3):310-8. PubMed ID: 18692266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.
    Christian JA; Bedford JL; Webb S; Brada M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):735-41. PubMed ID: 17187941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
    Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
    Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.
    Kron T; Grigorov G; Yu E; Yartsev S; Chen JZ; Wong E; Rodrigues G; Trenka K; Coad T; Bauman G; Van Dyk J
    Phys Med Biol; 2004 Aug; 49(16):3675-90. PubMed ID: 15446797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
    Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
    Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer--a planning study.
    Chan OS; Lee MC; Hung AW; Chang AT; Yeung RM; Lee AW
    Radiother Oncol; 2011 Nov; 101(2):298-302. PubMed ID: 21907438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques.
    Vogelius IS; Westerly DC; Cannon GM; Bentzen SM
    Acta Oncol; 2010 Oct; 49(7):1052-7. PubMed ID: 20831495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
    Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
    Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.